1. Home
  2. AVTX vs VOXR Comparison

AVTX vs VOXR Comparison

Compare AVTX & VOXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • VOXR
  • Stock Information
  • Founded
  • AVTX 2011
  • VOXR 2014
  • Country
  • AVTX United States
  • VOXR United States
  • Employees
  • AVTX N/A
  • VOXR N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • VOXR Precious Metals
  • Sector
  • AVTX Health Care
  • VOXR Basic Materials
  • Exchange
  • AVTX Nasdaq
  • VOXR Nasdaq
  • Market Cap
  • AVTX 248.3M
  • VOXR 293.7M
  • IPO Year
  • AVTX 2015
  • VOXR N/A
  • Fundamental
  • Price
  • AVTX $18.62
  • VOXR $4.62
  • Analyst Decision
  • AVTX Strong Buy
  • VOXR
  • Analyst Count
  • AVTX 9
  • VOXR 0
  • Target Price
  • AVTX $30.14
  • VOXR N/A
  • AVG Volume (30 Days)
  • AVTX 351.6K
  • VOXR 510.4K
  • Earning Date
  • AVTX 11-06-2025
  • VOXR 11-12-2025
  • Dividend Yield
  • AVTX N/A
  • VOXR 1.08%
  • EPS Growth
  • AVTX N/A
  • VOXR N/A
  • EPS
  • AVTX N/A
  • VOXR N/A
  • Revenue
  • AVTX $192,000.00
  • VOXR $12,158,304.00
  • Revenue This Year
  • AVTX N/A
  • VOXR $46.18
  • Revenue Next Year
  • AVTX N/A
  • VOXR $86.32
  • P/E Ratio
  • AVTX N/A
  • VOXR N/A
  • Revenue Growth
  • AVTX N/A
  • VOXR 9.06
  • 52 Week Low
  • AVTX $3.39
  • VOXR $2.21
  • 52 Week High
  • AVTX $19.41
  • VOXR $4.76
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 64.08
  • VOXR 63.77
  • Support Level
  • AVTX $16.75
  • VOXR $3.99
  • Resistance Level
  • AVTX $19.29
  • VOXR $4.36
  • Average True Range (ATR)
  • AVTX 1.41
  • VOXR 0.19
  • MACD
  • AVTX 0.17
  • VOXR 0.05
  • Stochastic Oscillator
  • AVTX 87.31
  • VOXR 94.12

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About VOXR Vox Royalty Corp.

Vox Royalty Corp is a returns-focused mining royalty company with a portfolio of royalties and streams spanning eight jurisdictions. It has built intellectual property, a technically focused transactional team, and a sourcing network which has allowed Vox to target the highest returns on royalty acquisitions in the mining royalty sector. The company geographically operates Australia, Nigeria, USA, and Brazil.

Share on Social Networks: